These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16965602)

  • 1. Hypomethylation of the protein gene product 9.5 promoter region in gallbladder cancer and its relationship with clinicopathological features.
    Lee YM; Lee JY; Kim MJ; Bae HI; Park JY; Kim SG; Kim DS
    Cancer Sci; 2006 Nov; 97(11):1205-10. PubMed ID: 16965602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor function of PGP9.5 is associated with epigenetic regulation in prostate cancer--novel predictor of biochemical recurrence after radical surgery.
    Mitsui Y; Shiina H; Hiraki M; Arichi N; Hiraoka T; Sumura M; Honda S; Yasumoto H; Igawa M
    Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):487-96. PubMed ID: 22246902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PGP9.5 methylation as a marker for metastatic colorectal cancer.
    Mizukami H; Shirahata A; Goto T; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
    Anticancer Res; 2008; 28(5A):2697-700. PubMed ID: 19035297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation status in the promoter region of the human PGP9.5 gene in cancer and normal tissues.
    Bittencourt Rosas SL; Caballero OL; Dong SM; da Costa Carvalho Mda G; Sidransky D; Jen J
    Cancer Lett; 2001 Sep; 170(1):73-9. PubMed ID: 11448537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of the Ras association domain family 1A (RASSF1A) gene in gallbladder cancer.
    Kee SK; Lee JY; Kim MJ; Lee SM; Jung YW; Kim YJ; Park JY; Bae HI; Hong HS; Yun YK; Kim SG; Kim DS
    Mol Cells; 2007 Dec; 24(3):364-71. PubMed ID: 18182852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation of DAP-kinase is associated with poor survival in primary biliary tract carcinoma patients.
    Tozawa T; Tamura G; Honda T; Nawata S; Kimura W; Makino N; Kawata S; Sugai T; Suto T; Motoyama T
    Cancer Sci; 2004 Sep; 95(9):736-40. PubMed ID: 15471559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PGP9.5 was less frequently methylated in advanced gastric carcinoma.
    Mizukami H; Goto T; Kitamura Y; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
    Hepatogastroenterology; 2009; 56(94-95):1576-9. PubMed ID: 19950834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter methylation profile in preneoplastic and neoplastic gallbladder lesions.
    García P; Manterola C; Araya JC; Villaseca M; Guzmán P; Sanhueza A; Thomas M; Alvarez H; Roa JC
    Mol Carcinog; 2009 Jan; 48(1):79-89. PubMed ID: 18543280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XAF1 is frequently methylated in human esophageal cancer.
    Chen XY; He QY; Guo MZ
    World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma.
    Shiba-Ishii A; Noguchi M
    Am J Pathol; 2012 Apr; 180(4):1653-62. PubMed ID: 22310466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.
    Ramezani F; Salami S; Omrani MD; Maleki D
    Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG methylation of promoter region inactivates E-cadherin gene in renal cell carcinoma.
    Nojima D; Nakajima K; Li LC; Franks J; Ribeiro-Filho L; Ishii N; Dahiya R
    Mol Carcinog; 2001 Sep; 32(1):19-27. PubMed ID: 11568972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines.
    Patel AC; Anna CH; Foley JF; Stockton PS; Tyson FL; Barrett JC; Devereux TR
    Carcinogenesis; 2000 Sep; 21(9):1691-700. PubMed ID: 10964101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma.
    Mandelker DL; Yamashita K; Tokumaru Y; Mimori K; Howard DL; Tanaka Y; Carvalho AL; Jiang WW; Park HL; Kim MS; Osada M; Mori M; Sidransky D
    Cancer Res; 2005 Jun; 65(11):4963-8. PubMed ID: 15930319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
    He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
    Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of fibulin-3 gene by promoter methylation in colorectal cancer predicts adverse prognosis.
    Tong JD; Jiao NL; Wang YX; Zhang YW; Han F
    Neoplasma; 2011; 58(5):441-8. PubMed ID: 21744999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of promoter methylation of VGF and PGP9.5 with ovarian cancer progression.
    Brait M; Maldonado L; Noordhuis MG; Begum S; Loyo M; Poeta ML; Barbosa A; Fazio VM; Angioli R; Rabitti C; Marchionni L; de Graeff P; van der Zee AG; Wisman GB; Sidransky D; Hoque MO
    PLoS One; 2013; 8(9):e70878. PubMed ID: 24086249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.
    Borges S; Döppler H; Perez EA; Andorfer CA; Sun Z; Anastasiadis PZ; Thompson E; Geiger XJ; Storz P
    Breast Cancer Res; 2013 Aug; 15(2):R66. PubMed ID: 23971832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer.
    Ling ZQ; Li P; Ge MH; Zhao X; Hu FJ; Fang XH; Dong ZM; Mao WM
    Int J Mol Med; 2011 May; 27(5):625-35. PubMed ID: 21373750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
    Mossman D; Kim KT; Scott RJ
    BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.